Fresenius Medical (FMS) Posts Quarterly Earnings, Beats Expectations By $0.05 EPS
Fresenius Medical (NYSE:FMS) issued its quarterly earnings data on Tuesday. The company reported $0.58 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.53 by $0.05, StockRatingsNetwork reports.
Fresenius Medical (NYSE:FMS) opened at 36.28 on Tuesday. Fresenius Medical has a one year low of $30.75 and a one year high of $37.01. The stock has a 50-day moving average of $35.84 and a 200-day moving average of $33.92. The company has a market cap of $21.824 billion and a P/E ratio of 21.78.
A number of research firms have recently commented on FMS. Analysts at JPMorgan Chase & Co. upgraded shares of Fresenius Medical from an “underweight” rating to a “neutral” rating in a research note on Wednesday, January 8th. Analysts at Morgan Stanley upgraded shares of Fresenius Medical from an “equal weight” rating to an “overweight” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the stock. Fresenius Medical has an average rating of “Hold” and a consensus price target of $38.33.
Fresenius Medical Care AG & Co KGaA (NYSE:FMS) is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.